Jan 9 (Reuters) - Novo Nordisk NOVOb.CO :
* OZEMPIC APPROVED IN CANADA FOR THE TREATMENT OF ADULTS WITH TYPE 2 DIABETES
* SAYS OZEMPIC DEMONSTRATED CLINICALLY MEANINGFUL IMPROVEMENTS IN BLOOD SUGAR AND BODY WEIGHT VERSUS COMPARATORS
Jan 9 (Reuters) - Novo Nordisk NOVOb.CO :
* OZEMPIC APPROVED IN CANADA FOR THE TREATMENT OF ADULTS WITH TYPE 2 DIABETES
* SAYS OZEMPIC DEMONSTRATED CLINICALLY MEANINGFUL IMPROVEMENTS IN BLOOD SUGAR AND BODY WEIGHT VERSUS COMPARATORS